Trophoblast Class I Major Histocompatibility Complex (MHC) Products Are Resistant to Rapid Degradation Imposed by the Human Cytomegalovirus (HCMV) Gene Products US2 and US11

US11 and US2 encode gene products expressed early in the replicative cycle of human cytomegalovirus (HCMV), which cause dislocation of human and murine major histocompatibility complex (MHC) class I molecules from the lumen of the endoplasmic reticulum to the cytosol, where the class I heavy chains are rapidly degraded. Human histocompatibility leukocyte antigens (HLA)-C and HLA-G are uniquely resistant to the effects of both US11 and US2 in a human trophoblast cell line as well as in porcine endothelial cells stably transfected with human class I genes. Dislocation and degradation of MHC class I heavy chains do not appear to involve cell type–specific factors, as US11 and US2 are fully active in this xenogeneic model. Importantly, trophoblasts HLA-G and HLA-C possess unique characteristics that allow their escape from HCMV-associated MHC class I degradation. Trophoblast class I molecules could serve not only to block recognition by natural killer cells, but also to guide virus-specific HLA-C– and possibly HLA-G–restricted cytotoxic T-lymphocytes to their targets.

[1]  H. Ploegh.  Viral strategies of immune evasion. , 1998, Science.

[2]  H. Ploegh,et al.  Why certain antibodies cross-react with HLA-A and HLA-G: epitope mapping of two common MHC class I reagents. , 1998, Molecular immunology.

[3]  D. Sachs,et al.  HLA-Cw3 expression on porcine endothelial cells protects against xenogeneic cytotoxicity mediated by a subset of human NK cells. , 1997, Journal of immunology.

[4]  A. Hammer,et al.  HLA Class I Expression on the Materno‐Fetal Interface , 1997, American journal of reproductive immunology.

[5]  Hidde L. Ploegh,et al.  In Vitro Translation and Assembly of a Complete T Cell Receptor–CD3 Complex , 1997, The Journal of experimental medicine.

[6]  S. Hiby,et al.  Evaluation of trophoblast HLA-G antigen with a specific monoclonal antibody. , 1997, Tissue antigens.

[7]  P. Cresswell,et al.  The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[8]  J. Dausset,et al.  The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors? , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[9]  U. Koszinowski,et al.  A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter. , 1997, Immunity.

[10]  A. Mellor,et al.  HLA-G functions as a restriction element and a transplantation antigen in mice. , 1997, International immunology.

[11]  P. A. Peterson,et al.  The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. , 1997, Immunity.

[12]  J. Dausset,et al.  HLA-G gene polymorphism segregation within CEPH reference families. , 1997, Human immunology.

[13]  H. Ploegh,et al.  The HCMV Gene Products US11 and US2 Differ in Their Ability to Attack Allelic Forms of Murine Major Histocompatibility Complex (MHC) Class I Heavy Chains , 1997, The Journal of experimental medicine.

[14]  T. Rapoport,et al.  Sec6l-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction , 1996, Nature.

[15]  P. Ebbesen,et al.  Expression of HLA class I molecules in human first trimester and term placenta trophoblast , 1996, Cell and Tissue Research.

[16]  O. Mandelboim,et al.  Protection from Natural Killer Cell-Mediated Lysis by HLA-G Expression on Target Cells , 1996, Science.

[17]  H. Ploegh,et al.  Herpes simplex virus blocks intracellular transport of HLA-G in placentally derived human cells. , 1996, Journal of immunology.

[18]  H. Ploegh,et al.  Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[19]  P. A. Peterson,et al.  Human cytomegalovirus inhibits antigen presentation by a sequential multistep process. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[20]  D. Geraghty,et al.  Expression of HLA-G in human mononuclear phagocytes and selective induction by IFN-gamma. , 1996, Journal of immunology.

[21]  D. Sachs,et al.  Derivation of immortalized swine stromal cell lines. , 1996, Transplantation proceedings.

[22]  A. Sharkey,et al.  Evidence for the expression of HLAA-C class I mRNA and protein by human first trimester trophoblast. , 1996, Journal of immunology.

[23]  M. Bogyo,et al.  The Human Cytomegalovirus US11 Gene Product Dislocates MHC Class I Heavy Chains from the Endoplasmic Reticulum to the Cytosol , 1996, Cell.

[24]  J. Bajorath,et al.  The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association. , 1995, Immunity.

[25]  L. Sun,et al.  Multiple independent loci within the human cytomegalovirus unique short region down-regulate expression of major histocompatibility complex class I heavy chains , 1995, Journal of virology.

[26]  J. Yewdell,et al.  Herpes simplex virus turns off the TAP to evade host immunity , 1995, Nature.

[27]  P. A. Peterson,et al.  A viral inhibitor of peptide transporters for antigen presentation , 1995, Nature.

[28]  P. Parham,et al.  Low HLA-C expression at cell surfaces correlates with increased turnover of heavy chain mRNA , 1995, The Journal of experimental medicine.

[29]  H. Ploegh,et al.  Getting the inside out: the transporter associated with antigen processing (TAP) and the presentation of viral antigen. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[30]  C. Ober,et al.  HLA-G polymorphisms in African Americans. , 1994, Journal of immunology.

[31]  B. Drénou,et al.  The HLA-G gene is expressed at a low mRNA level in different human cells and tissues. , 1994, Human immunology.

[32]  R. Fauchet,et al.  Evidence for a polymorphism of HLA-G gene. , 1993, Human immunology.

[33]  H. Ploegh,et al.  Human cytomegalovirus down-regulates HLA class I expression by reducing the stability of class I H chains. , 1993, Journal of immunology.

[34]  N. Holmes,et al.  In situ hybridization and northern blot demonstration of HLA-G mRNA in human trophoblast populations by locus-specific oligonucleotide. , 1993, Human immunology.

[35]  J. Zemmour,et al.  Distinctive polymorphism at the HLA-C locus: implications for the expression of HLA-C , 1992, The Journal of experimental medicine.

[36]  H. Orr,et al.  HLA and maternal‐fetal recognition , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[37]  J. Fishback,et al.  Analysis of HLA-G mRNA in human placental and extraplacental membrane cells by in situ hybridization. , 1991, Journal of immunology.

[38]  A. Grabowska,et al.  Human Trophoblast Cells in Culture Express an Unusual Major Histocompatibility Complex Class I‐Like Antigen , 1990, American journal of reproductive immunology.

[39]  S. Weissman,et al.  The mRNA of a human class I gene HLA G/HLA 6.0 exhibits a restricted pattern of expression. , 1990, Nucleic acids research.

[40]  S. Fisher,et al.  A class I antigen, HLA-G, expressed in human trophoblasts. , 1990, Science.

[41]  T. F. Rinke de Wit,et al.  Differential expression of the HLA class I multigene family by human embryonal carcinoma and choriocarcinoma cell lines. , 1990, Journal of immunology.

[42]  M. Palmer,et al.  Human trophoblast and the choriocarcinoma cell line BeWo express a truncated HLA Class I molecule. , 1990, Journal of immunology.

[43]  T. F. Rinke de Wit,et al.  NOVEL HUMAN MHC CLASS I GENES ARE EXPRESSED BY TUMOUR CELL LINES REPRESENTING EMBRYONIC AND EXTRAEMBRYONIC TISSUES , 1989, Journal of immunogenetics.

[44]  C. Hart,et al.  Immunity to cytomegalovirus in women with unexplained recurrent spontaneous abortion. , 1986, American journal of reproductive immunology and microbiology : AJRIM.

[45]  A. McMichael,et al.  Evidence for a novel HLA antigen found on human extravillous trophoblast and a choriocarcinoma cell line. , 1986, Immunology.

[46]  H. Ploegh,et al.  Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products. , 1986, Journal of immunology.

[47]  A. McMichael,et al.  Class 1 major histocompatibility complex antigens on human extra-villous trophoblast. , 1984, Immunology.

[48]  C. Barnstable,et al.  Use of a monoclonal antibody (W6/32) in structural studies of HLA-A,B,C, antigens. , 1979, Journal of immunology.

[49]  C. Barnstable,et al.  Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis , 1978, Cell.

[50]  G. Altshuler.  Immunologic Competence of the Immature Human Fetus: Morphologic Evidence From Intrauterine Cytomegalovirus Infection , 1974, Obstetrics and gynecology.

[51]  J. D. Poland,et al.  Cytomegalovirus isolations associated with pregnancy wastage. , 1970, American journal of obstetrics and gynecology.

[52]  M. Arekkirszenbaum.  The a1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: Is HLA-G the public ligand for natural killer cell inhibitory receptors? , 1997 .

[53]  Y. Taketani,et al.  HLA-G gene polymorphism in a Japanese population , 1996, Immunogenetics.